Uematsu T - Search Results

1

Pilot study of the uricosuric effect of DuP-753, a new angiotensin II receptor antagonist, in healthy subjects.

Nakashima M, Uematsu T, Kosuge K, Kanamaru M. Nakashima M, et al. Among authors: uematsu t. Eur J Clin Pharmacol. 1992;42(3):333-5. doi: 10.1007/BF00266358. Eur J Clin Pharmacol. 1992. PMID: 1577054 Clinical Trial.

2

Pharmacokinetics of temocapril hydrochloride, a novel angiotensin converting enzyme inhibitor, in renal insufficiency.

Nakashima M, Yamamoto J, Shibata M, Uematsu T, Shinjo H, Akahori T, Shioya H, Sugiyama K, Kawahara Y. Nakashima M, et al. Among authors: uematsu t. Eur J Clin Pharmacol. 1992;43(6):657-9. doi: 10.1007/BF02284968. Eur J Clin Pharmacol. 1992. PMID: 1493850

3

Pharmacokinetic and pharmacodynamic profiles of vapiprost, a selective, long-lasting thromboxane receptor antagonist, after single and multiple oral administration to healthy volunteers.

Uematsu T, Nagashima S, Mizuno A, Hirano K, Nakashima M. Uematsu T, et al. J Clin Pharmacol. 1991 Sep;31(9):815-22. doi: 10.1002/j.1552-4604.1991.tb01917.x. J Clin Pharmacol. 1991. PMID: 1839540

4

The measurement of ofloxacin in hair as an index of exposure.

Uematsu T, Miyazawa N, Nakashima M. Uematsu T, et al. Eur J Clin Pharmacol. 1991;40(6):581-4. doi: 10.1007/BF00279974. Eur J Clin Pharmacol. 1991. PMID: 1884739

5

Phase I study of Y-20811, a new long-acting thromboxane synthetase inhibitor by oral administration.

Nakashima M, Uematsu T, Takiguchi Y, Mizuno A, Kanamaru M. Nakashima M, et al. Among authors: uematsu t. J Clin Pharmacol. 1989 Jun;29(6):568-76. doi: 10.1002/j.1552-4604.1989.tb03384.x. J Clin Pharmacol. 1989. PMID: 2754025

6

Phase I clinical studies of 7432-S, a new oral cephalosporin: safety and pharmacokinetics.

Nakashima M, Uematsu T, Takiguchi Y, Mizuno A, Iida M, Yoshida T, Yamamoto S, Kitagawa K, Oguma T, Ishii H, et al. Nakashima M, et al. Among authors: uematsu t. J Clin Pharmacol. 1988 Mar;28(3):246-52. doi: 10.1002/j.1552-4604.1988.tb03140.x. J Clin Pharmacol. 1988. PMID: 3360973 Clinical Trial.

7

Pharmacokinetics and safety of l-carnitine infused i.v. in healthy subjects.

Uematsu T, Itaya T, Nishimoto M, Takiguchi Y, Mizuno A, Nakashima M, Yoshinobu K, Hasebe T. Uematsu T, et al. Eur J Clin Pharmacol. 1988;34(2):213-6. doi: 10.1007/BF00614562. Eur J Clin Pharmacol. 1988. PMID: 3383994 Clinical Trial.

8

Phase I study of cefixime, a new oral cephalosporin.

Nakashima M, Uematsu T, Takiguchi Y, Kanamaru M. Nakashima M, et al. Among authors: uematsu t. J Clin Pharmacol. 1987 May-Jun;27(5):425-31. doi: 10.1002/j.1552-4604.1987.tb03043.x. J Clin Pharmacol. 1987. PMID: 3693588

9

Effects of losartan, an angiotensin II antagonist, on the development of cardiac hypertrophy due to volume overload.

Ishiye M, Umemura K, Uematsu T, Nakashima M. Ishiye M, et al. Among authors: uematsu t. Biol Pharm Bull. 1995 May;18(5):700-4. doi: 10.1248/bpb.18.700. Biol Pharm Bull. 1995. PMID: 7492986 Free article.

10

Angiotensin AT1 receptor-mediated attenuation of cardiac hypertrophy due to volume overload: involvement of endothelin.

Ishiye M, Umemura K, Uematsu T, Nakashima M. Ishiye M, et al. Among authors: uematsu t. Eur J Pharmacol. 1995 Jun 23;280(1):11-7. doi: 10.1016/0014-2999(95)00167-j. Eur J Pharmacol. 1995. PMID: 7498249

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

644 results

Search Page

Filters